An Adaptive First in Man Dose-Escalation Study of NGX267: Statistical, Clinical, and Operational Considerations

By Ivanova Anastasia  

Journal of Biopharmaceutical Statistics, Vol. 19, Iss. 2, 2009-03 ,pp. : 247-255

Taylor & Francis Ltd

Access to resources Recommend Favorite

A Phase IIa Open-Label Dose-Escalation Pilot Study Using Allogeneic Human Dermal Fibroblasts for Nasolabial Folds

By LOWE NICHOLAS J.   LOWE PHILIPPA L.   St CLAIR ROBERTS JOHN  

Dermatologic Surgery, Vol. 36, Iss. 10, 2010-10 ,pp. : 1578-1585

Elsevier

Access to resources Recommend Favorite

Long-Term Safety and Tolerability of the Oral Direct Renin Inhibitor Aliskiren with Optional Add-On Hydrochlorothiazide in Patients with Hypertension: A Randomized, Open-Label, Parallel-Group, Multicentre, Dose-Escalation Study with an Extension Phase

By Sica Domenic  

Clinical Drug Investigation, Vol. 31, Iss. 12, 2011-12 ,pp. : 825-837

Adis International

Access to resources Recommend Favorite

Effect of a Simple Dose-Escalation Schedule on Tramadol Tolerability: Assessment in the Clinical Setting

By I. Tagarro  

Clinical Drug Investigation, Vol. 25, Iss. 1, 2005-01 ,pp. : 23-31

Adis International

Access to resources Recommend Favorite

Infliximab dose escalation not uncommon during first year in RA

By  

Inpharma, Vol. 1, Iss. 1520, 2006-01 ,pp. : 6-6

Adis International

Access to resources Recommend Favorite